New York, Oct. 08, 2019 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Gene Therapy Industry" - https://www.reportlinker.com/p05817594/?utm_source=GNW

- Representing the developed world, the United States will maintain a 30% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$133.3 Million to the region’s size and clout in the next 5 to 6 years. Over US$117.2 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Lentivirus will reach a market size of US$6.5 Million by the close of the analysis period. As the world’s second largest economy and the new game changer in global markets, China exhibits the potential to grow at 39.2% over the next couple of years and add approximately US$797 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

- Competitors identified in this market include among others, American Gene Technologies Inc.; Applied Genetic Technologies Corporation; Benitec BioPharma; BioMarin Pharmaceutical, Inc.; bluebird bio, Inc.; Brammer Bio; Bristol-Myers Squibb Company; Celgene Corporation; Cellectis; CELLforCURE; CEVEC Pharmaceuticals GmbH; Chiesi Farmaceutici SpA; CSL Behring; Gensight Biologics S.A.; Gilead Sciences, Inc.; GlaxoSmithKline PLC; Human Stem Cells Institute PJSC (HSCI); Juno Therapeutics, Inc.; Lonza Group Ltd.; Novartis International AG; Novasep Holding SAS; Orchard Therapeutics Ltd.; Oxford Biomedica plc; REGENXBIO, Inc.; Sanofi Genzyme; Shanghai Sunway Biotech Co., Ltd.; Shenzhen SiBiono GeneTech Co., Ltd.; Shire PLC; Taxus Cardium Pharmaceuticals Group; Transgene SA; Ultragenyx Pharmaceutical, Inc.; uniQure NV; Voyager Therapeutics, Inc.


Read the full report: https://www.reportlinker.com/p05817594/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Global Competitor Market Shares
Gene Therapy Competitor Market Share Scenario Worldwide (in %):
2019 & 2028
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: Gene Therapy Global Market Estimates and Forecasts in
US$ Thousand by Region/Country: 2018-2025
Table 2: Gene Therapy Global Retrospective Market Scenario in
US$ Thousand by Region/Country: 2009-2017
Table 3: Gene Therapy Market Share Shift across Key Geographies
Worldwide: 2009 VS 2019 VS 2025
Table 4: Lentivirus (Vector) World Market by Region/Country in
US$ Thousand: 2018 to 2025
Table 5: Lentivirus (Vector) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 6: Lentivirus (Vector) Market Share Breakdown of
Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
Table 7: AAV (Vector) Potential Growth Markets Worldwide in US$
Thousand: 2018 to 2025
Table 8: AAV (Vector) Historic Market Perspective by
Region/Country in US$ Thousand: 2009 to 2017
Table 9: AAV (Vector) Market Sales Breakdown by Region/Country
in Percentage: 2009 VS 2019 VS 2025
Table 10: RetroVirus & Gamma RetroVirus (Vector) Geographic
Market Spread Worldwide in US$ Thousand: 2018 to 2025
Table 11: RetroVirus & Gamma RetroVirus (Vector) Region Wise
Breakdown of Global Historic Demand in US$ Thousand: 2009 to
2017
Table 12: RetroVirus & Gamma RetroVirus (Vector) Market Share
Distribution in Percentage by Region/Country: 2009 VS 2019 VS
2025
Table 13: Modified Herpes Simplex Virus (Vector) World Market
Estimates and Forecasts by Region/Country in US$ Thousand: 2018
to 2025
Table 14: Modified Herpes Simplex Virus (Vector) Market
Historic Review by Region/Country in US$ Thousand: 2009 to 2017
Table 15: Modified Herpes Simplex Virus (Vector) Market Share
Breakdown by Region/Country: 2009 VS 2019 VS 2025
Table 16: Adenovirus (Vector) World Market by Region/Country in
US$ Thousand: 2018 to 2025
Table 17: Adenovirus (Vector) Historic Market Analysis by
Region/Country in US$ Thousand: 2009 to 2017
Table 18: Adenovirus (Vector) Market Share Distribution in
Percentage by Region/Country: 2009 VS 2019 VS 2025
Table 19: Other Applications (Vector) World Market Estimates
and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
Table 20: Other Applications (Vector) Market Worldwide Historic
Review by Region/Country in US$ Thousand: 2009 to 2017
Table 21: Other Applications (Vector) Market Percentage Share
Distribution by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Gene Therapy Market Share (in %) by Company: 2019 & 2025
Table 22: United States Gene Therapy Market Estimates and
Projections in US$ Thousand by Vector: 2018 to 2025
Table 23: Gene Therapy Market in the United States by Vector: A
Historic Review in US$ Thousand for 2009-2017
Table 24: United States Gene Therapy Market Share Breakdown by
Vector: 2009 VS 2019 VS 2025
CANADA
Table 25: Canadian Gene Therapy Market Estimates and Forecasts
in US$ Thousand by Vector: 2018 to 2025
Table 26: Canadian Gene Therapy Historic Market Review by
Vector in US$ Thousand: 2009-2017
Table 27: Gene Therapy Market in Canada: Percentage Share
Breakdown of Sales by Vector for 2009, 2019, and 2025
JAPAN
Table 28: Japanese Market for Gene Therapy: Annual Sales
Estimates and Projections in US$ Thousand by Vector for the
Period 2018-2025
Table 29: Gene Therapy Market in Japan: Historic Sales Analysis
in US$ Thousand by Vector for the Period 2009-2017
Table 30: Japanese Gene Therapy Market Share Analysis by
Vector: 2009 VS 2019 VS 2025
CHINA
Table 31: Chinese Gene Therapy Market Growth Prospects in US$
Thousand by Vector for the Period 2018-2025
Table 32: Gene Therapy Historic Market Analysis in China in US$
Thousand by Vector: 2009-2017
Table 33: Chinese Gene Therapy Market by Vector: Percentage
Breakdown of Sales for 2009, 2019, and 2025
EUROPE
Market Facts & Figures
European Gene Therapy Market: Competitor Market Share Scenario
(in %) for 2019 & 2025
Table 34: European Gene Therapy Market Demand Scenario in US$
Thousand by Region/Country: 2018-2025
Table 35: Gene Therapy Market in Europe: A Historic Market
Perspective in US$ Thousand by Region/Country for the Period
2009-2017
Table 36: European Gene Therapy Market Share Shift by
Region/Country: 2009 VS 2019 VS 2025
Table 37: European Gene Therapy Market Estimates and Forecasts
in US$ Thousand by Vector: 2018-2025
Table 38: Gene Therapy Market in Europe in US$ Thousand by
Vector: A Historic Review for the Period 2009-2017
Table 39: European Gene Therapy Market Share Breakdown by
Vector: 2009 VS 2019 VS 2025
FRANCE
Table 40: Gene Therapy Market in France by Vector: Estimates
and Projections in US$ Thousand for the Period 2018-2025
Table 41: French Gene Therapy Historic Market Scenario in US$
Thousand by Vector: 2009-2017
Table 42: French Gene Therapy Market Share Analysis by Vector:
2009 VS 2019 VS 2025
GERMANY
Table 43: Gene Therapy Market in Germany: Recent Past, Current
and Future Analysis in US$ Thousand by Vector for the Period
2018-2025
Table 44: German Gene Therapy Historic Market Analysis in US$
Thousand by Vector: 2009-2017
Table 45: German Gene Therapy Market Share Breakdown by Vector:
2009 VS 2019 VS 2025
ITALY
Table 46: Italian Gene Therapy Market Growth Prospects in US$
Thousand by Vector for the Period 2018-2025
Table 47: Gene Therapy Historic Market Analysis in Italy in US$
Thousand by Vector: 2009-2017
Table 48: Italian Gene Therapy Market by Vector: Percentage
Breakdown of Sales for 2009, 2019, and 2025
UNITED KINGDOM
Table 49: United Kingdom Market for Gene Therapy: Annual Sales
Estimates and Projections in US$ Thousand by Vector for the
Period 2018-2025
Table 50: Gene Therapy Market in the United Kingdom: Historic
Sales Analysis in US$ Thousand by Vector for the Period
2009-2017
Table 51: United Kingdom Gene Therapy Market Share Analysis by
Vector: 2009 VS 2019 VS 2025
SPAIN
Table 52: Spanish Gene Therapy Market Estimates and Forecasts
in US$ Thousand by Vector: 2018 to 2025
Table 53: Spanish Gene Therapy Historic Market Review by Vector
in US$ Thousand: 2009-2017
Table 54: Gene Therapy Market in Spain: Percentage Share
Breakdown of Sales by Vector for 2009, 2019, and 2025
RUSSIA
Table 55: Russian Gene Therapy Market Estimates and Projections
in US$ Thousand by Vector: 2018 to 2025
Table 56: Gene Therapy Market in Russia by Vector: A Historic
Review in US$ Thousand for 2009-2017
Table 57: Russian Gene Therapy Market Share Breakdown by
Vector: 2009 VS 2019 VS 2025
REST OF EUROPE
Table 58: Rest of Europe Gene Therapy Market Estimates and
Forecasts in US$ Thousand by Vector: 2018-2025
Table 59: Gene Therapy Market in Rest of Europe in US$ Thousand
by Vector: A Historic Review for the Period 2009-2017
Table 60: Rest of Europe Gene Therapy Market Share Breakdown by
Vector: 2009 VS 2019 VS 2025
ASIA-PACIFIC
Table 61: Asia-Pacific Gene Therapy Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 62: Gene Therapy Market in Asia-Pacific: Historic Market
Analysis in US$ Thousand by Region/Country for the Period
2009-2017
Table 63: Asia-Pacific Gene Therapy Market Share Analysis by
Region/Country: 2009 VS 2019 VS 2025
Table 64: Gene Therapy Market in Asia-Pacific by Vector:
Estimates and Projections in US$ Thousand for the Period
2018-2025
Table 65: Asia-Pacific Gene Therapy Historic Market Scenario in
US$ Thousand by Vector: 2009-2017
Table 66: Asia-Pacific Gene Therapy Market Share Analysis by
Vector: 2009 VS 2019 VS 2025
AUSTRALIA
Table 67: Gene Therapy Market in Australia: Recent Past,
Current and Future Analysis in US$ Thousand by Vector for the
Period 2018-2025
Table 68: Australian Gene Therapy Historic Market Analysis in
US$ Thousand by Vector: 2009-2017
Table 69: Australian Gene Therapy Market Share Breakdown by
Vector: 2009 VS 2019 VS 2025
INDIA
Table 70: Indian Gene Therapy Market Estimates and Forecasts in
US$ Thousand by Vector: 2018 to 2025
Table 71: Indian Gene Therapy Historic Market Review by Vector
in US$ Thousand: 2009-2017
Table 72: Gene Therapy Market in India: Percentage Share
Breakdown of Sales by Vector for 2009, 2019, and 2025
SOUTH KOREA
Table 73: Gene Therapy Market in South Korea: Recent Past,
Current and Future Analysis in US$ Thousand by Vector for the
Period 2018-2025
Table 74: South Korean Gene Therapy Historic Market Analysis in
US$ Thousand by Vector: 2009-2017
Table 75: Gene Therapy Market Share Distribution in South Korea
by Vector: 2009 VS 2019 VS 2025
REST OF ASIA-PACIFIC
Table 76: Rest of Asia-Pacific Market for Gene Therapy: Annual
Sales Estimates and Projections in US$ Thousand by Vector for
the Period 2018-2025
Table 77: Gene Therapy Market in Rest of Asia-Pacific: Historic
Sales Analysis in US$ Thousand by Vector for the Period
2009-2017
Table 78: Rest of Asia-Pacific Gene Therapy Market Share
Analysis by Vector: 2009 VS 2019 VS 2025
LATIN AMERICA
Table 79: Latin American Gene Therapy Market Trends by
Region/Country in US$ Thousand: 2018-2025
Table 80: Gene Therapy Market in Latin America in US$ Thousand
by Region/Country: A Historic Perspective for the Period
2009-2017
Table 81: Latin American Gene Therapy Market Percentage
Breakdown of Sales by Region/Country: 2009, 2019, and 2025
Table 82: Latin American Gene Therapy Market Growth Prospects
in US$ Thousand by Vector for the Period 2018-2025
Table 83: Gene Therapy Historic Market Analysis in Latin
America in US$ Thousand by Vector: 2009-2017
Table 84: Latin American Gene Therapy Market by Vector:
Percentage Breakdown of Sales for 2009, 2019, and 2025
ARGENTINA
Table 85: Argentinean Gene Therapy Market Estimates and
Forecasts in US$ Thousand by Vector: 2018-2025
Table 86: Gene Therapy Market in Argentina in US$ Thousand by
Vector: A Historic Review for the Period 2009-2017
Table 87: Argentinean Gene Therapy Market Share Breakdown by
Vector: 2009 VS 2019 VS 2025
BRAZIL
Table 88: Gene Therapy Market in Brazil by Vector: Estimates
and Projections in US$ Thousand for the Period 2018-2025
Table 89: Brazilian Gene Therapy Historic Market Scenario in
US$ Thousand by Vector: 2009-2017
Table 90: Brazilian Gene Therapy Market Share Analysis by
Vector: 2009 VS 2019 VS 2025
MEXICO
Table 91: Gene Therapy Market in Mexico: Recent Past, Current
and Future Analysis in US$ Thousand by Vector for the Period
2018-2025
Table 92: Mexican Gene Therapy Historic Market Analysis in US$
Thousand by Vector: 2009-2017
Table 93: Mexican Gene Therapy Market Share Breakdown by
Vector: 2009 VS 2019 VS 2025
REST OF LATIN AMERICA
Table 94: Rest of Latin America Gene Therapy Market Estimates
and Projections in US$ Thousand by Vector: 2018 to 2025
Table 95: Gene Therapy Market in Rest of Latin America by
Vector: A Historic Review in US$ Thousand for 2009-2017
Table 96: Rest of Latin America Gene Therapy Market Share
Breakdown by Vector: 2009 VS 2019 VS 2025
MIDDLE EAST
Table 97: The Middle East Gene Therapy Market Estimates and
Forecasts in US$ Thousand by Region/Country: 2018-2025
Table 98: Gene Therapy Market in the Middle East by
Region/Country in US$ Thousand: 2009-2017
Table 99: The Middle East Gene Therapy Market Share Breakdown
by Region/Country: 2009, 2019, and 2025
Table 100: The Middle East Gene Therapy Market Estimates and
Forecasts in US$ Thousand by Vector: 2018 to 2025
Table 101: The Middle East Gene Therapy Historic Market by
Vector in US$ Thousand: 2009-2017
Table 102: Gene Therapy Market in the Middle East: Percentage
Share Breakdown of Sales by Vector for 2009, 2019, and 2025
IRAN
Table 103: Iranian Market for Gene Therapy: Annual Sales
Estimates and Projections in US$ Thousand by Vector for the
Period 2018-2025
Table 104: Gene Therapy Market in Iran: Historic Sales Analysis
in US$ Thousand by Vector for the Period 2009-2017
Table 105: Iranian Gene Therapy Market Share Analysis by
Vector: 2009 VS 2019 VS 2025
ISRAEL
Table 106: Israeli Gene Therapy Market Estimates and Forecasts
in US$ Thousand by Vector: 2018-2025
Table 107: Gene Therapy Market in Israel in US$ Thousand by
Vector: A Historic Review for the Period 2009-2017
Table 108: Israeli Gene Therapy Market Share Breakdown by
Vector: 2009 VS 2019 VS 2025
SAUDI ARABIA
Table 109: Saudi Arabian Gene Therapy Market Growth Prospects
in US$ Thousand by Vector for the Period 2018-2025
Table 110: Gene Therapy Historic Market Analysis in Saudi
Arabia in US$ Thousand by Vector: 2009-2017
Table 111: Saudi Arabian Gene Therapy Market by Vector:
Percentage Breakdown of Sales for 2009, 2019, and 2025
UNITED ARAB EMIRATES
Table 112: Gene Therapy Market in the United Arab Emirates:
Recent Past, Current and Future Analysis in US$ Thousand by
Vector for the Period 2018-2025
Table 113: United Arab Emirates Gene Therapy Historic Market
Analysis in US$ Thousand by Vector: 2009-2017
Table 114: Gene Therapy Market Share Distribution in United
Arab Emirates by Vector: 2009 VS 2019 VS 2025
REST OF MIDDLE EAST
Table 115: Gene Therapy Market in Rest of Middle East: Recent
Past, Current and Future Analysis in US$ Thousand by Vector for
the Period 2018-2025
Table 116: Rest of Middle East Gene Therapy Historic Market
Analysis in US$ Thousand by Vector: 2009-2017
Table 117: Rest of Middle East Gene Therapy Market Share
Breakdown by Vector: 2009 VS 2019 VS 2025
AFRICA
Table 118: African Gene Therapy Market Estimates and
Projections in US$ Thousand by Vector: 2018 to 2025
Table 119: Gene Therapy Market in Africa by Vector: A Historic
Review in US$ Thousand for 2009-2017
Table 120: African Gene Therapy Market Share Breakdown by
Vector: 2009 VS 2019 VS 2025

IV. COMPETITION

AMERICAN GENE TECHNOLOGIES INC.
APPLIED GENETIC TECHNOLOGIES CORPORATION
BENITEC BIOPHARMA
BIOMARIN PHARMACEUTICAL
BLUEBIRD BIO
BRAMMER BIO
BRISTOL-MYERS SQUIBB COMPANY
CELGENE CORPORATION
CELLECTIS
CELLFORCURE
CEVEC PHARMACEUTICALS GMBH
CHIESI FARMACEUTICI SPA
CSL BEHRING
GENSIGHT BIOLOGICS S.A.
GILEAD SCIENCES
GLAXOSMITHKLINE PLC
HUMAN STEM CELLS INSTITUTE PJSC (HSCI)
JUNO THERAPEUTICS, INC.
LONZA GROUP AG
NOVARTIS INTERNATIONAL AG
NOVASEP HOLDING SAS
OXFORD BIOMEDICA PLC
REGENXBIO
SANOFI GENZYME
SHANGHAI SUNWAY BIOTECH
SHENZHEN SIBIONO GENETECH
SHIRE PLC
TAXUS CARDIUM PHARMACEUTICALS GROUP
TRANSGENE SA
ULTRAGENYX PHARMACEUTICAL
UNIQURE NV
VOYAGER THERAPEUTICS

V. CURATED RESEARCH
Read the full report: https://www.reportlinker.com/p05817594/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001